📌 Inotropic agents – MilrinonePhosphodiesterase-3 inhibitor. Inotrope + vasodilator (reduces afterload). Preferred in cardiogenic shock with elevated SVR. Loading dose: 50 mcg/kg IV over 10-60 min, infusion 0.25-1 mcg/kg/min.
📌 Inotropic agents – Dobutamineβ1-agonist, inotrope + mild vasodilator. Increases contractility, HR. Dose 2-20 mcg/kg/min. Less arrhythmogenic than dopamine.
📌 Inotropic agents – DopamineLow dose (2-5 mcg/kg/min): renal vasodilation. Medium dose (5-10 mcg/kg/min): β1 inotrope. High dose (>10 mcg/kg/min): α vasoconstriction. Use with caution.
📌 EpinephrineMixed α/β agonist. Potent inotrope and vasoconstrictor. Used for refractory shock. Dose 0.01-1 mcg/kg/min. Risk of arrhythmias, increased afterload.
📌 VasopressinUsed in catecholamine-resistant vasodilatory shock (sepsis). May cause hyponatremia, cardiac ischemia.
📌 Mechanical circulatory support – ECMOVeno-arterial (VA) ECMO for cardiogenic shock. Indications: refractory shock, cardiac arrest (ECPR), bridge to recovery or transplant. Complications: bleeding, thrombosis, infection.
📌 Ventricular Assist Devices (VAD)Berlin Heart EXCOR (infants), HeartMate 3 (older children). Bridge to transplant or recovery. Paracorporeal or implantable.
📌 Post-cardiotomy shockLow cardiac output after CHD surgery. Treat: milrinone, ECMO if refractory. Risk factors: prolonged bypass, young age, residual lesions.
4️⃣ Mechanical circulatory support ▪ VA-ECMO for refractory cardiogenic shock (fulminant myocarditis, post-cardiotomy). ▪ VAD as bridge to transplant (DCM, chronic HF). ▪ Indications: inability to wean inotropes, end-organ dysfunction, lactate rising.
5️⃣ Treat underlying cause ▪ Myocarditis: IVIG (controversial), ECMO if fulminant. ▪ Post-cardiotomy: re-explore if residual lesion, milrinone, ECMO. ▪ Arrhythmia: cardioversion, antiarrhythmics. ▪ Tamponade: pericardiocentesis.
6️⃣ Monitoring ▪ Continuous ECG, invasive BP, central venous pressure, pulse oximetry. ▪ Serial lactate, ABG, electrolytes, urine output. ▪ Echocardiogram daily to assess recovery.
7️⃣ Transition & long-term follow-up ▪ Wean inotropes as LV function improves. ▪ Transition to oral heart failure therapy (ACE inhibitors, beta-blockers). ▪ VAD or transplant evaluation if no recovery.
❓ Reflex prompt 1: A 6-month-old post-cardiac surgery, BP 60/30, cold extremities, lactate 8 mmol/L. Next step? ✅ Answer: Start milrinone, assess for residual lesion (echo). Consider ECMO if refractory.
❓ Reflex prompt 2: A 12-year-old with fulminant myocarditis, on high-dose epinephrine, BP 70/40, lactate rising. Next step? ✅ Answer: VA-ECMO (bridge to recovery).
❓ Reflex prompt 3: A 4-year-old with DCM, LVEF 15%, on milrinone and epinephrine, still hypotensive. Next step? ✅ Answer: VAD as bridge to transplant (Berlin Heart).
❓ Reflex prompt 4: A neonate with severe aortic stenosis, cardiogenic shock, ductal-dependent. Next step? ✅ Answer: PGE1 infusion, balloon valvuloplasty, ECMO if needed.
❓ Reflex prompt 5: A 14-year-old with septic shock and myocardial depression, BP 60/40, EF 35%. Inotrope of choice? ✅ Answer: Milrinone + norepinephrine. Dobutamine alternative.